Author

Christopher P. Tinworth

GlaxoSmithKline (United Kingdom)ORCID 0000-0002-2756-707XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Alex Phillipou· 1 shared Ashley P. Hancock· 1 shared Chloe L. TayleriD· 1 shared David F. ToughiD· 1 shared David J. HirstiD· 1 shared Despoina KoumantouiD· 1 shared Efstratios StratikosiD· 1 shared Giovanni Vitulli· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alex Phillipou

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintNov 17, 2025

Discovery of an orally available potent ER aminopeptidase 1 (ERAP1) inhibitor that enhances anti-tumor responses and limits inflammatory autoimmunity in vivo.

Christopher P. Tinworth, Justyna Wojno, Michael Adam…·Efstratios Stratikos

DOI 10.1101/2025.11.17.686761

mouseexperimental assay

𝕏 PostBluesky